EVALUATION ON THE SAFETY OF TICAGRELOR AMONG INDIAN ACUTE CORONARY SYNDROME (ACS) PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION
Journal Title: Journal of Evidence Based Medicine and Healthcare - Year 2018, Vol 5, Issue 38
Abstract
BACKGROUND Ticagrelor is the novel class of anti-platelet drugs, has a simpler and faster metabolism (rapid onset of action), high potency and most importantly reversibility. The latter makes this drug safer in patients with bleeding complications. With this background, we studied the safety and tolerability of ticagrelor in Indian patients with acute coronary syndrome undergoing PCI. Primary Objective was to find out the assessment of bleeding events (major, minor or minimal) in acute coronary syndrome patients on Ticagrelor undergoing PCI. Secondary objective was to assess the incidence of dyspnea and other adverse events during 6- months follow up. MATERIALS AND METHODS This was single center, prospective, observational study involving 200 patients hospitalized in Medanta, The Medicity, Hospital, Gurgaon because of ACS undergoing PCI and were treated with Ticagrelor (180mg loading dose and 90mg thereafter) between December 2015 to May 2016. Study Design: Prospective Observational Study. RESULTS Total bleeding was observed in 29 (14.5%) patients, in which major bleeding was seen in 08 (4%) patients, minor bleeding was seen in 07 (3.5%) patients, minimal bleeding was observed in 13 (6.5%) patients, and fatal bleeding was seen in 01 (0.5%) patient Upper Gastro-Intestinal Bleeding (UGIB) was most commonly seen, followed by ecchymosis, lower gastrointestinal bleeding, haematuria, nasal bleeding, haemoptysis and intracranial haemorrhage. Dyspnea was observed in 39 (19.5%) patients among whom only 02 (1%) required discontinuation of study drug. CONCLUSION Study showed that Ticagrelor is a safe newer antiplatelet drug. Since chance of bleeding was significantly higher in females and diabetics, care should be taken in these patients with high risk for bleeding. Also, incidence of major bleeding and myocardial infarction was seen significantly less in our patients as compared to western counter parts. As our study was small observational study, these conclusions need to be confirmed with larger randomized trials in Indian patients.
Authors and Affiliations
Nabi Maknoo G. H. , Mayank Jain, Himanshu Dabral, Rajneesh Kapoor
Keywords
Related Articles
- EP ID EP572268
- DOI 10.18410/jebmh/2018/561
- Views 70
- Downloads 0
A STUDY ON PAEDIATRIC DERMATOSES IN CHILDREN ATTENDING OPD OF GVR HOSPITAL, KURNOOL
BACKGROUND Paediatric dermatoses include various diseases of neonates such as sebaceous hyperplasia, milia, sucking blisters etc., cutaneous infections such as impetigo, folliculitis, furuncles etc., arthropod bites and...
FOETAL-VITELLINE DUCT CYST WITH HINDGUT AGENESIS- A RARE CASE REPORT
BACKGROUND This is a case of 22-year-old female patient with 14 weeks live foetus, underwent routine ultrasound scan where a large intraabdominal cyst was found. Foetus has been aborted and later subjected to autopsy whe...
DIAPHYSEAL NUTRIENT FORAMINA OF THE FIBULA IN EASTERN INDIA
BACKGROUND Vascular supply of the fibula assumes importance during trauma and surgical procedures in the leg region, as the fibula is a donor for bone grafts, and is also used in vascularized bone microsurgery. We studie...
CLINICOPATHOLOGICAL STUDY OF PAPULOSQUAMOUS SKIN LESIONS
BACKGROUND Papulosquamous lesions form the largest group of skin diseases. Since, they are all characterized by scaling papules or plaques, clinical confusion may result in their diagnosis, hence definitive histopatholog...
PROTEIN S DEFICIENCY WITH PORTAL VEIN THROMBOSIS: A CASE REPORT
Portal vein thrombosis is a rare cause of portal hypertension associated mainly with cirrhosis, thrombophilia and malignancy. In young patient search of risk factor and underlying etiology can change the management and p...